SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Biocept Inc. – ‘10-Q’ for 9/30/22 – ‘XML’

On:  Monday, 11/21/22, at 4:10pm ET   ·   For:  9/30/22   ·   Accession #:  1564590-22-38094   ·   File #:  1-36284

Previous ‘10-Q’:  ‘10-Q’ on 11/10/22 for 6/30/22   ·   Next:  ‘10-Q/A’ on 4/17/23 for 9/30/22   ·   Latest:  ‘10-Q’ on 8/14/23 for 6/30/23   ·   22 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/21/22  Biocept Inc.                      10-Q        9/30/22   60:7.7M                                   ActiveDisclosure/FA

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   2.49M 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     25K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     25K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     20K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     20K 
11: R1          Document and Entity Information                     HTML     71K 
12: R2          Condensed Balance Sheets                            HTML    114K 
13: R3          Condensed Balance Sheets (Parenthetical)            HTML     36K 
14: R4          Condensed Statements of Operations (Unaudited)      HTML     96K 
15: R5          Condensed Statements of Stockholders' Equity        HTML     82K 
16: R6          Condensed Statements of Cash Flows (Unaudited)      HTML    103K 
17: R7          The Company, Business Activities and Basis of       HTML    135K 
                Presentation                                                     
18: R8          Liquidity                                           HTML     23K 
19: R9          Sales of Equity Securities                          HTML     27K 
20: R10         Balance Sheet Details                               HTML    108K 
21: R11         Payor Liability                                     HTML     21K 
22: R12         Leases                                              HTML    123K 
23: R13         Stock-Based Compensation                            HTML    111K 
24: R14         Common Stock Warrants Outstanding                   HTML     61K 
25: R15         Net Loss per Common Share                           HTML     45K 
26: R16         Commitments and Contingencies                       HTML     22K 
27: R17         Related Party Transactions                          HTML     23K 
28: R18         Subsequent Events                                   HTML     21K 
29: R19         The Company, Business Activities and Basis of       HTML    143K 
                Presentation (Policies)                                          
30: R20         The Company, Business Activities and Basis of       HTML    106K 
                Presentation (Tables)                                            
31: R21         Balance Sheet Details (Tables)                      HTML    108K 
32: R22         Leases (Tables)                                     HTML    121K 
33: R23         Stock-Based Compensation (Tables)                   HTML    115K 
34: R24         Common Stock Warrants Outstanding (Tables)          HTML     61K 
35: R25         Net Loss per Common Share (Tables)                  HTML     43K 
36: R26         The Company, Business Activities and Basis of       HTML     45K 
                Presentation - Additional Information (Detail)                   
37: R27         The Company, Business Activities and Basis of       HTML     37K 
                Presentation - Composition of Net Revenues                       
                Recognized Disaggregated by Source (Detail)                      
38: R28         The Company, Business Activities and Basis of       HTML     37K 
                Presentation - Summary of Third-Party Payers That                
                Represent More Than 10% of Total Net Revenues and                
                Total Accounts Receivable (Detail)                               
39: R29         Liquidity - Additional Information (Detail)         HTML     44K 
40: R30         Sales of Equity Securities - Additional             HTML     63K 
                Information (Detail)                                             
41: R31         Balance Sheet Details - Schedule of Fixed Assets    HTML     70K 
                and Accrued Liabilities (Detail)                                 
42: R32         Leases - Additional Information (Detail)            HTML     89K 
43: R33         Leases - Schedule of Lease Expense (Detail)         HTML     28K 
44: R34         Leases - Schedule of Represents Maturities of       HTML     57K 
                Operating and Finance Lease Liabilities (Detail)                 
45: R35         Leases - Supplemental Cash Flow Information         HTML     25K 
                Related to Operating and Finance Leases (Detail)                 
46: R36         Stock-Based Compensation - Additional Information   HTML     43K 
                (Detail)                                                         
47: R37         Stock-Based Compensation - Summary of Stock Option  HTML     43K 
                Activity (Detail)                                                
48: R38         Stock-Based Compensation - Assumptions Used for     HTML     35K 
                Determining Fair Value of Stock Options Under                    
                Black-Scholes Pricing Model (Detail)                             
49: R39         Stock-Based Compensation - Effects of Stock-Based   HTML     33K 
                Compensation Related to Equity Awards to Employees               
                and Nonemployees on Condensed Statement of                       
                Operations and Comprehensive Loss (Detail)                       
50: R40         Common Stock Warrants Outstanding - Summary of      HTML     28K 
                Equity-Classified Common Stock Warrant Activity                  
                (Detail)                                                         
51: R41         Common Stock Warrants Outstanding - Additional      HTML     26K 
                Information (Detail)                                             
52: R42         Net Loss per Common Share - Additional Information  HTML     25K 
                (Detail)                                                         
53: R43         Net Loss per Common Share - Schedule of             HTML     31K 
                Anti-Dilutive Securities Excluded from                           
                Computations of Diluted Weighted-Average Shares                  
                (Detail)                                                         
54: R44         Commitments and Contingencies - Additional          HTML     22K 
                Information (Detail)                                             
55: R45         Related Party Transactions - Additional             HTML     26K 
                Information (Detail)                                             
58: XML         IDEA XML File -- Filing Summary                      XML    106K 
56: XML         XBRL Instance -- bioc-10q_20220930_htm               XML   1.71M 
57: EXCEL       IDEA Workbook of Financial Reports                  XLSX    101K 
 7: EX-101.CAL  XBRL Calculations -- bioc-20220930_cal               XML    158K 
 8: EX-101.DEF  XBRL Definitions -- bioc-20220930_def                XML    324K 
 9: EX-101.LAB  XBRL Labels -- bioc-20220930_lab                     XML   1.02M 
10: EX-101.PRE  XBRL Presentations -- bioc-20220930_pre              XML    687K 
 6: EX-101.SCH  XBRL Schema -- bioc-20220930                         XSD    154K 
59: JSON        XBRL Instance as JSON Data -- MetaLinks              308±   485K 
60: ZIP         XBRL Zipped Folder -- 0001564590-22-038094-xbrl      Zip    304K

‘XML’   —   IDEA XML File — Filing Summary

This Document is an IDEA XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<FilingSummary>
<Version> 3.22.2.2 </Version>
<ProcessingTime/>
<ReportFormat> html </ReportFormat>
<ContextCount> 175 </ContextCount>
<ElementCount> 266 </ElementCount>
<EntityCount> 1 </EntityCount>
<FootnotesReported> true </FootnotesReported>
<SegmentCount> 42 </SegmentCount>
<ScenarioCount> 0 </ScenarioCount>
<TuplesReported> false </TuplesReported>
<UnitCount> 6 </UnitCount>
<MyReports>
<Report instance="bioc-10q_20220930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R1.htm </HtmlFileName>
<LongName> 100000 - Document - Document and Entity Information </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation </Role>
<ShortName> Document and Entity Information </ShortName>
<MenuCategory> Cover </MenuCategory>
<Position> 1 </Position>
</Report>
<Report instance="bioc-10q_20220930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R2.htm </HtmlFileName>
<LongName> 100010 - Statement - Condensed Balance Sheets </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220930/taxonomy/role/StatementCondensedBalanceSheets </Role>
<ShortName> Condensed Balance Sheets </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 2 </Position>
</Report>
<Report instance="bioc-10q_20220930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R3.htm </HtmlFileName>
<LongName> 100020 - Statement - Condensed Balance Sheets (Parenthetical) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220930/taxonomy/role/StatementCondensedBalanceSheetsParenthetical </Role>
<ShortName> Condensed Balance Sheets (Parenthetical) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 3 </Position>
</Report>
<Report instance="bioc-10q_20220930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R4.htm </HtmlFileName>
<LongName> 100030 - Statement - Condensed Statements of Operations (Unaudited) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220930/taxonomy/role/StatementCondensedStatementsOfOperationsUnaudited </Role>
<ShortName> Condensed Statements of Operations (Unaudited) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 4 </Position>
</Report>
<Report instance="bioc-10q_20220930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R5.htm </HtmlFileName>
<LongName> 100040 - Statement - Condensed Statements of Stockholders' Equity </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220930/taxonomy/role/StatementCondensedStatementsOfStockholdersEquity </Role>
<ShortName> Condensed Statements of Stockholders' Equity </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 5 </Position>
</Report>
<Report instance="bioc-10q_20220930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R6.htm </HtmlFileName>
<LongName> 100050 - Statement - Condensed Statements of Cash Flows (Unaudited) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220930/taxonomy/role/StatementCondensedStatementsOfCashFlowsUnaudited </Role>
<ShortName> Condensed Statements of Cash Flows (Unaudited) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 6 </Position>
</Report>
<Report instance="bioc-10q_20220930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R7.htm </HtmlFileName>
<LongName> 100060 - Disclosure - The Company, Business Activities and Basis of Presentation </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220930/taxonomy/role/DisclosureTheCompanyBusinessActivitiesAndBasisOfPresentation </Role>
<ShortName> The Company, Business Activities and Basis of Presentation </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 7 </Position>
</Report>
<Report instance="bioc-10q_20220930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R8.htm </HtmlFileName>
<LongName> 100070 - Disclosure - Liquidity </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220930/taxonomy/role/DisclosureLiquidity </Role>
<ShortName> Liquidity </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 8 </Position>
</Report>
<Report instance="bioc-10q_20220930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R9.htm </HtmlFileName>
<LongName> 100080 - Disclosure - Sales of Equity Securities </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220930/taxonomy/role/DisclosureSalesOfEquitySecurities </Role>
<ShortName> Sales of Equity Securities </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 9 </Position>
</Report>
<Report instance="bioc-10q_20220930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R10.htm </HtmlFileName>
<LongName> 100090 - Disclosure - Balance Sheet Details </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220930/taxonomy/role/DisclosureBalanceSheetDetails </Role>
<ShortName> Balance Sheet Details </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 10 </Position>
</Report>
<Report instance="bioc-10q_20220930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R11.htm </HtmlFileName>
<LongName> 100100 - Disclosure - Payor Liability </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220930/taxonomy/role/DisclosurePayorLiability </Role>
<ShortName> Payor Liability </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 11 </Position>
</Report>
<Report instance="bioc-10q_20220930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R12.htm </HtmlFileName>
<LongName> 100110 - Disclosure - Leases </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220930/taxonomy/role/DisclosureLeases </Role>
<ShortName> Leases </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 12 </Position>
</Report>
<Report instance="bioc-10q_20220930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R13.htm </HtmlFileName>
<LongName> 100120 - Disclosure - Stock-Based Compensation </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220930/taxonomy/role/DisclosureStockBasedCompensation </Role>
<ShortName> Stock-Based Compensation </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 13 </Position>
</Report>
<Report instance="bioc-10q_20220930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R14.htm </HtmlFileName>
<LongName> 100130 - Disclosure - Common Stock Warrants Outstanding </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220930/taxonomy/role/DisclosureCommonStockWarrantsOutstanding </Role>
<ShortName> Common Stock Warrants Outstanding </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 14 </Position>
</Report>
<Report instance="bioc-10q_20220930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R15.htm </HtmlFileName>
<LongName> 100140 - Disclosure - Net Loss per Common Share </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220930/taxonomy/role/DisclosureNetLossPerCommonShare </Role>
<ShortName> Net Loss per Common Share </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 15 </Position>
</Report>
<Report instance="bioc-10q_20220930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R16.htm </HtmlFileName>
<LongName> 100150 - Disclosure - Commitments and Contingencies </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220930/taxonomy/role/DisclosureCommitmentsAndContingencies </Role>
<ShortName> Commitments and Contingencies </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 16 </Position>
</Report>
<Report instance="bioc-10q_20220930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R17.htm </HtmlFileName>
<LongName> 100160 - Disclosure - Related Party Transactions </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220930/taxonomy/role/DisclosureRelatedPartyTransactions </Role>
<ShortName> Related Party Transactions </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 17 </Position>
</Report>
<Report instance="bioc-10q_20220930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R18.htm </HtmlFileName>
<LongName> 100170 - Disclosure - Subsequent Events </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220930/taxonomy/role/DisclosureSubsequentEvents </Role>
<ShortName> Subsequent Events </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 18 </Position>
</Report>
<Report instance="bioc-10q_20220930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R19.htm </HtmlFileName>
<LongName> 100180 - Disclosure - The Company, Business Activities and Basis of Presentation (Policies) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220930/taxonomy/role/DisclosureTheCompanyBusinessActivitiesAndBasisOfPresentationPolicies </Role>
<ShortName> The Company, Business Activities and Basis of Presentation (Policies) </ShortName>
<MenuCategory> Policies </MenuCategory>
<Position> 19 </Position>
</Report>
<Report instance="bioc-10q_20220930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R20.htm </HtmlFileName>
<LongName> 100190 - Disclosure - The Company, Business Activities and Basis of Presentation (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220930/taxonomy/role/DisclosureTheCompanyBusinessActivitiesAndBasisOfPresentationTables </Role>
<ShortName> The Company, Business Activities and Basis of Presentation (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.biocept.com/20220930/taxonomy/role/DisclosureTheCompanyBusinessActivitiesAndBasisOfPresentation </ParentRole>
<Position> 20 </Position>
</Report>
<Report instance="bioc-10q_20220930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R21.htm </HtmlFileName>
<LongName> 100200 - Disclosure - Balance Sheet Details (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220930/taxonomy/role/DisclosureBalanceSheetDetailsTables </Role>
<ShortName> Balance Sheet Details (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.biocept.com/20220930/taxonomy/role/DisclosureBalanceSheetDetails </ParentRole>
<Position> 21 </Position>
</Report>
<Report instance="bioc-10q_20220930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R22.htm </HtmlFileName>
<LongName> 100210 - Disclosure - Leases (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220930/taxonomy/role/DisclosureLeasesTables </Role>
<ShortName> Leases (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.biocept.com/20220930/taxonomy/role/DisclosureLeases </ParentRole>
<Position> 22 </Position>
</Report>
<Report instance="bioc-10q_20220930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R23.htm </HtmlFileName>
<LongName> 100220 - Disclosure - Stock-Based Compensation (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220930/taxonomy/role/DisclosureStockBasedCompensationTables </Role>
<ShortName> Stock-Based Compensation (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.biocept.com/20220930/taxonomy/role/DisclosureStockBasedCompensation </ParentRole>
<Position> 23 </Position>
</Report>
<Report instance="bioc-10q_20220930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R24.htm </HtmlFileName>
<LongName> 100230 - Disclosure - Common Stock Warrants Outstanding (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220930/taxonomy/role/DisclosureCommonStockWarrantsOutstandingTables </Role>
<ShortName> Common Stock Warrants Outstanding (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.biocept.com/20220930/taxonomy/role/DisclosureCommonStockWarrantsOutstanding </ParentRole>
<Position> 24 </Position>
</Report>
<Report instance="bioc-10q_20220930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R25.htm </HtmlFileName>
<LongName> 100240 - Disclosure - Net Loss per Common Share (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220930/taxonomy/role/DisclosureNetLossPerCommonShareTables </Role>
<ShortName> Net Loss per Common Share (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.biocept.com/20220930/taxonomy/role/DisclosureNetLossPerCommonShare </ParentRole>
<Position> 25 </Position>
</Report>
<Report instance="bioc-10q_20220930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R26.htm </HtmlFileName>
<LongName> 100250 - Disclosure - The Company, Business Activities and Basis of Presentation - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220930/taxonomy/role/DisclosureTheCompanyBusinessActivitiesAndBasisOfPresentationAdditionalInformationDetail </Role>
<ShortName> The Company, Business Activities and Basis of Presentation - Additional Information (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 26 </Position>
</Report>
<Report instance="bioc-10q_20220930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R27.htm </HtmlFileName>
<LongName> 100260 - Disclosure - The Company, Business Activities and Basis of Presentation - Composition of Net Revenues Recognized Disaggregated by Source (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220930/taxonomy/role/DisclosureTheCompanyBusinessActivitiesAndBasisOfPresentationCompositionOfNetRevenuesRecognizedDisaggregatedBySourceDetail </Role>
<ShortName> The Company, Business Activities and Basis of Presentation - Composition of Net Revenues Recognized Disaggregated by Source (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 27 </Position>
</Report>
<Report instance="bioc-10q_20220930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R28.htm </HtmlFileName>
<LongName> 100270 - Disclosure - The Company, Business Activities and Basis of Presentation - Summary of Third-Party Payers That Represent More Than 10% of Total Net Revenues and Total Accounts Receivable (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220930/taxonomy/role/DisclosureTheCompanyBusinessActivitiesAndBasisOfPresentationSummaryOfThirdPartyPayersThatRepresentMoreThan10OfTotalNetRevenuesAndTotalAccountsReceivableDetail </Role>
<ShortName> The Company, Business Activities and Basis of Presentation - Summary of Third-Party Payers That Represent More Than 10% of Total Net Revenues and Total Accounts Receivable (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 28 </Position>
</Report>
<Report instance="bioc-10q_20220930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R29.htm </HtmlFileName>
<LongName> 100280 - Disclosure - Liquidity - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220930/taxonomy/role/DisclosureLiquidityAdditionalInformationDetail </Role>
<ShortName> Liquidity - Additional Information (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 29 </Position>
</Report>
<Report instance="bioc-10q_20220930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R30.htm </HtmlFileName>
<LongName> 100290 - Disclosure - Sales of Equity Securities - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220930/taxonomy/role/DisclosureSalesOfEquitySecuritiesAdditionalInformationDetail </Role>
<ShortName> Sales of Equity Securities - Additional Information (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 30 </Position>
</Report>
<Report instance="bioc-10q_20220930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R31.htm </HtmlFileName>
<LongName> 100300 - Disclosure - Balance Sheet Details - Schedule of Fixed Assets and Accrued Liabilities (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220930/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfFixedAssetsAndAccruedLiabilitiesDetail </Role>
<ShortName> Balance Sheet Details - Schedule of Fixed Assets and Accrued Liabilities (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 31 </Position>
</Report>
<Report instance="bioc-10q_20220930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R32.htm </HtmlFileName>
<LongName> 100310 - Disclosure - Leases - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220930/taxonomy/role/DisclosureLeasesAdditionalInformationDetail </Role>
<ShortName> Leases - Additional Information (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 32 </Position>
</Report>
<Report instance="bioc-10q_20220930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R33.htm </HtmlFileName>
<LongName> 100320 - Disclosure - Leases - Schedule of Lease Expense (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220930/taxonomy/role/DisclosureLeasesScheduleOfLeaseExpenseDetail </Role>
<ShortName> Leases - Schedule of Lease Expense (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 33 </Position>
</Report>
<Report instance="bioc-10q_20220930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R34.htm </HtmlFileName>
<LongName> 100330 - Disclosure - Leases - Schedule of Represents Maturities of Operating and Finance Lease Liabilities (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220930/taxonomy/role/DisclosureLeasesScheduleOfRepresentsMaturitiesOfOperatingAndFinanceLeaseLiabilitiesDetail </Role>
<ShortName> Leases - Schedule of Represents Maturities of Operating and Finance Lease Liabilities (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 34 </Position>
</Report>
<Report instance="bioc-10q_20220930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R35.htm </HtmlFileName>
<LongName> 100350 - Disclosure - Leases - Supplemental Cash Flow Information Related to Operating and Finance Leases (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220930/taxonomy/role/DisclosureLeasesSupplementalCashFlowInformationRelatedToOperatingAndFinanceLeasesDetail </Role>
<ShortName> Leases - Supplemental Cash Flow Information Related to Operating and Finance Leases (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 35 </Position>
</Report>
<Report instance="bioc-10q_20220930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R36.htm </HtmlFileName>
<LongName> 100360 - Disclosure - Stock-Based Compensation - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220930/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail </Role>
<ShortName> Stock-Based Compensation - Additional Information (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 36 </Position>
</Report>
<Report instance="bioc-10q_20220930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R37.htm </HtmlFileName>
<LongName> 100370 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220930/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetail </Role>
<ShortName> Stock-Based Compensation - Summary of Stock Option Activity (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 37 </Position>
</Report>
<Report instance="bioc-10q_20220930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R38.htm </HtmlFileName>
<LongName> 100380 - Disclosure - Stock-Based Compensation - Assumptions Used for Determining Fair Value of Stock Options Under Black-Scholes Pricing Model (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220930/taxonomy/role/DisclosureStockBasedCompensationAssumptionsUsedForDeterminingFairValueOfStockOptionsUnderBlackScholesPricingModelDetail </Role>
<ShortName> Stock-Based Compensation - Assumptions Used for Determining Fair Value of Stock Options Under Black-Scholes Pricing Model (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 38 </Position>
</Report>
<Report instance="bioc-10q_20220930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R39.htm </HtmlFileName>
<LongName> 100390 - Disclosure - Stock-Based Compensation - Effects of Stock-Based Compensation Related to Equity Awards to Employees and Nonemployees on Condensed Statement of Operations and Comprehensive Loss (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220930/taxonomy/role/DisclosureStockBasedCompensationEffectsOfStockBasedCompensationRelatedToEquityAwardsToEmployeesAndNonemployeesOnCondensedStatementOfOperationsAndComprehensiveLossDetail </Role>
<ShortName> Stock-Based Compensation - Effects of Stock-Based Compensation Related to Equity Awards to Employees and Nonemployees on Condensed Statement of Operations and Comprehensive Loss (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 39 </Position>
</Report>
<Report instance="bioc-10q_20220930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R40.htm </HtmlFileName>
<LongName> 100400 - Disclosure - Common Stock Warrants Outstanding - Summary of Equity-Classified Common Stock Warrant Activity (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220930/taxonomy/role/DisclosureCommonStockWarrantsOutstandingSummaryOfEquityClassifiedCommonStockWarrantActivityDetail </Role>
<ShortName> Common Stock Warrants Outstanding - Summary of Equity-Classified Common Stock Warrant Activity (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 40 </Position>
</Report>
<Report instance="bioc-10q_20220930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R41.htm </HtmlFileName>
<LongName> 100410 - Disclosure - Common Stock Warrants Outstanding - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220930/taxonomy/role/DisclosureCommonStockWarrantsOutstandingAdditionalInformationDetail </Role>
<ShortName> Common Stock Warrants Outstanding - Additional Information (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 41 </Position>
</Report>
<Report instance="bioc-10q_20220930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R42.htm </HtmlFileName>
<LongName> 100420 - Disclosure - Net Loss per Common Share - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220930/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetail </Role>
<ShortName> Net Loss per Common Share - Additional Information (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 42 </Position>
</Report>
<Report instance="bioc-10q_20220930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R43.htm </HtmlFileName>
<LongName> 100430 - Disclosure - Net Loss per Common Share - Schedule of Anti-Dilutive Securities Excluded from Computations of Diluted Weighted-Average Shares (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220930/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfAntiDilutiveSecuritiesExcludedFromComputationsOfDilutedWeightedAverageSharesDetail </Role>
<ShortName> Net Loss per Common Share - Schedule of Anti-Dilutive Securities Excluded from Computations of Diluted Weighted-Average Shares (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 43 </Position>
</Report>
<Report instance="bioc-10q_20220930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R44.htm </HtmlFileName>
<LongName> 100440 - Disclosure - Commitments and Contingencies - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220930/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail </Role>
<ShortName> Commitments and Contingencies - Additional Information (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 44 </Position>
</Report>
<Report instance="bioc-10q_20220930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R45.htm </HtmlFileName>
<LongName> 100450 - Disclosure - Related Party Transactions - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220930/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail </Role>
<ShortName> Related Party Transactions - Additional Information (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 45 </Position>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<LongName> All Reports </LongName>
<ReportType> Book </ReportType>
<ShortName> All Reports </ShortName>
</Report>
</MyReports>
<Logs>
<Log type="Warning"> [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 13 fact(s) appearing in ix:hidden were eligible for transformation: bioc:ClassOfWarrantsOrRightsWeightedAverageRemainingContractualLife, bioc:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountRateBondEquivalentYield, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate, us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1, us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2, us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1 - bioc-10q_20220930.htm 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39 </Log>
</Logs>
<InputFiles>
<File doctype="10-Q" original="bioc-10q_20220930.htm"> bioc-10q_20220930.htm </File>
<File> bioc-20220930.xsd </File>
<File> bioc-20220930_cal.xml </File>
<File> bioc-20220930_def.xml </File>
<File> bioc-20220930_lab.xml </File>
<File> bioc-20220930_pre.xml </File>
<File> bioc-ex311_9.htm </File>
<File> bioc-ex312_6.htm </File>
<File> bioc-ex321_10.htm </File>
<File> bioc-ex322_7.htm </File>
</InputFiles>
<SupplementalFiles/>
<BaseTaxonomies>
<BaseTaxonomy items="1"> http://fasb.org/srt/2021-01-31 </BaseTaxonomy>
<BaseTaxonomy items="506"> http://fasb.org/us-gaap/2021-01-31 </BaseTaxonomy>
<BaseTaxonomy items="29"> http://xbrl.sec.gov/dei/2021q4 </BaseTaxonomy>
</BaseTaxonomies>
<HasPresentationLinkbase> true </HasPresentationLinkbase>
<HasCalculationLinkbase> true </HasCalculationLinkbase>
</FilingSummary>

22 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/24/22  Biocept Inc.                      8-K:5,9     3/22/22   11:148K                                   Donnelley … Solutions/FA
11/16/20  Biocept Inc.                      10-Q        9/30/20   70:8.7M                                   ActiveDisclosure/FA
 9/04/20  Biocept Inc.                      8-K:3,5,9   9/03/20    2:62K                                    ActiveDisclosure/FA
 1/09/20  Biocept Inc.                      8-K:1,3,9   1/09/20    3:284K                                   ActiveDisclosure/FA
12/11/19  Biocept Inc.                      8-K:8,9    12/09/19    4:290K                                   ActiveDisclosure/FA
12/06/19  Biocept Inc.                      S-1/A                  3:816K                                   ActiveDisclosure/FA
 5/29/19  Biocept Inc.                      8-K:1,3,9   5/28/19    3:273K                                   ActiveDisclosure/FA
 3/18/19  Biocept Inc.                      8-K:1,3,8,9 3/15/19    6:670K                                   ActiveDisclosure/FA
11/28/18  Biocept Inc.                      S-1                    4:827K                                   ActiveDisclosure/FA
 9/24/18  Biocept Inc.                      8-K:1,3,8,9 9/20/18    7:830K                                   ActiveDisclosure/FA
 8/13/18  Biocept Inc.                      8-K:3,5,8,9 8/09/18    3:463K                                   ActiveDisclosure/FA
 7/11/18  Biocept Inc.                      S-1/A                 15:3.6M                                   Donnelley … Solutions/FA
 7/06/18  Biocept Inc.                      8-K:3,5,9   7/06/18    2:57K                                    ActiveDisclosure/FA
 1/30/18  Biocept Inc.                      8-K:8,9     1/30/18    2:161K                                   ActiveDisclosure/FA
 1/22/18  Biocept Inc.                      S-1/A                 86:9.1M                                   Donnelley … Solutions/FA
 9/29/17  Biocept Inc.                      8-K:5,9     9/27/17    2:49K                                    ActiveDisclosure/FA
 8/10/17  Biocept Inc.                      8-K:1,3,9   8/09/17    3:333K                                   ActiveDisclosure/FA
 3/30/17  Biocept Inc.                      8-K:1,3,8,9 3/28/17    7:627K                                   ActiveDisclosure/FA
 9/29/16  Biocept Inc.                      8-K:5,8,9   9/27/16    3:319K                                   ActiveDisclosure/FA
 5/06/14  Biocept Inc.                      8-K:1,2,3,9 4/30/14    3:366K                                   Donnelley … Solutions/FA
 2/14/14  Biocept Inc.                      8-K:1,3,5,8 2/10/14    3:368K                                   Donnelley … Solutions/FA
 9/23/13  Biocept Inc.                      S-1¶                  71:6.2M                                   Donnelley … Solutions/FA
↑Top
Filing Submission 0001564590-22-038094   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Tue., May 14, 10:13:46.2am ET